Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Tigress Financial 

Dolby Laboratories Inc. A diskutieren

Dolby Laboratories Inc. A

WKN: A0DNCY / Symbol: DLB / Name: Dolby / Aktie / Medien & Verlagswesen / Mid Cap /

54,50 €
0,94 %

Einschätzung Buy
Rendite (%) -33,55 %
Kursziel 95,02
Veränderung
Endet am 27.01.26

Dolby Laboratories, Inc. (NYSE: DLB) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $100.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -30,61 %
Kursziel 95,60
Veränderung
Endet am 30.01.26

Dolby Laboratories, Inc. (NYSE: DLB) had its "buy" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $100.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Dolby Laboratories, Inc. (NYSE: DLB) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -36,25 %
Kursziel 96,20
Veränderung
Endet am 13.02.26

Dolby Laboratories, Inc. (NYSE: DLB) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $100.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -18,05 %
Kursziel 88,54
Veränderung
Endet am 02.05.26

Dolby Laboratories, Inc. (NYSE: DLB) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $100.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,55 %
Kursziel 100,04
Veränderung
Endet am 15.05.26

Dolby Laboratories, Inc. (NYSE: DLB) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -20,31 %
Kursziel 82,26
Veränderung
Endet am 13.06.26

Dolby Laboratories, Inc. (NYSE: DLB) had its "buy" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $95.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,10 %
Kursziel 97,80
Veränderung
Endet am 15.08.26

Dolby Laboratories (NYSE: DLB) had its price target raised by analysts at Tigress Financial from $112.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,38 %
Kursziel 85,26
Veränderung
Endet am 12.09.26

Dolby Laboratories (NYSE:DLB) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $100.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,39 %
Kursziel 82,06
Veränderung
Endet am 19.11.26

Dolby Laboratories (NYSE:DLB) had its price target lowered by analysts at Barrington Research from $100.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,39 %
Kursziel 73,42
Veränderung
Endet am 19.11.26

Dolby Laboratories (NYSE:DLB) had its price target lowered by analysts at Rosenblatt Securities from $95.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,77 %
Kursziel 72,71
Veränderung
Endet am 22.01.27

Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,81 %
Kursziel 75,81
Veränderung
Endet am 26.01.27

Dolby Laboratories (NYSE:DLB) had its price target lowered by analysts at Barrington Research from $95.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for DLB provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,93 %
Kursziel 71,38
Veränderung
Endet am 30.01.27

Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Ratings data for DLB provided by MarketBeat